Sentante Endovascular Robotic Platform
[commercial]surgical · food-service · 2 deployments in catalog
Manufacturer
SentanteForm Factor
surgical
Lifecycle
commercial
Operational Reality
Audited
Deployments
2
Target Price
Custom Quote
- SURGICAL
- COMMERCIAL
Description
CE-marked endovascular robotic platform with haptic force feedback for remote vascular interventions.
Key facts & specs
- website
- https://www.medtechdive.com/news/sentante-lands-europes-ce-mark-for-endovascular-robot/820918/
- lifecycle
- active
- manufacturer
- Sentante
- deployments count
- 2
- Maturity stage
- commercial
- Form Factor
- surgical
- Maturity
- commercial
Safety record
No incidents on record for Sentante Endovascular Robotic Platform.
FAQ
What is Sentante Endovascular Robotic Platform?
CE-marked endovascular robotic platform with haptic force feedback for remote vascular interventions.
Is Sentante Endovascular Robotic Platform actually deployed in the real world?
Yes. Sentante Endovascular Robotic Platform is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Sentante Endovascular Robotic Platform?
Sentante Endovascular Robotic Platform is made by Sentante, based in Vilnius, Lithuania.
Where is Sentante Endovascular Robotic Platform deployed?
2 verified deployments of Sentante Endovascular Robotic Platform are on the DEPLOY registry, including at United States (multiple hotel chains), Germany, Europe.
Can you buy Sentante Endovascular Robotic Platform?
Sentante Endovascular Robotic Platform is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
What are alternatives to Sentante Endovascular Robotic Platform?
On the DEPLOY registry, comparable surgical robots to Sentante Endovascular Robotic Platform include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.
How does Sentante Endovascular Robotic Platform compare to da Vinci (and Ion)?
Sentante Endovascular Robotic Platform and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. Sentante Endovascular Robotic Platform has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Sentante Endovascular Robotic Platform a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Sentante Endovascular Robotic Platform ranks in roughly the top 30% of surgical models tracked by the registry.
What is Sentante Endovascular Robotic Platform's maturity stage?
Sentante Endovascular Robotic Platform is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is Sentante Endovascular Robotic Platform safe?
Sentante Endovascular Robotic Platform has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.